2013
DOI: 10.1093/neuonc/not183
|View full text |Cite
|
Sign up to set email alerts
|

Omics and Prognstic Markers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A number of prominent somatic mutations (namely TP53, RB1, NF1, EGFR, and PDGFRA) were found to be associated with volumetric parameters on T1 contrast and T2 FLAIR MR images [43]. The first purely quantitative analysis integrated GBM "multi-omics" data, containing multiple "-omes" such as the genome, transcriptome, and proteome, from the TCGA and their corresponding images from The Cancer Imaging Archive (TCIA) [44,45]. Zinn et al identified "radiomic profiles" that helped to discriminate the mutational landscape (i.e., TP53, PTEN, and EGFR) on a dataset of 29 TCGA patients [46].…”
Section: Brainmentioning
confidence: 99%
“…A number of prominent somatic mutations (namely TP53, RB1, NF1, EGFR, and PDGFRA) were found to be associated with volumetric parameters on T1 contrast and T2 FLAIR MR images [43]. The first purely quantitative analysis integrated GBM "multi-omics" data, containing multiple "-omes" such as the genome, transcriptome, and proteome, from the TCGA and their corresponding images from The Cancer Imaging Archive (TCIA) [44,45]. Zinn et al identified "radiomic profiles" that helped to discriminate the mutational landscape (i.e., TP53, PTEN, and EGFR) on a dataset of 29 TCGA patients [46].…”
Section: Brainmentioning
confidence: 99%